Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/23 16:29 | 3/16/23 | ACOR | Health | BioPrd | Biological Products, (No Diag | Cohen Ron | NY | DO | P,CEO | P.m | 13 | 0.6248 | 0 | 20 | 16 | 150 | D | ||||||||||||||
8/31/17 16:50 | 8/29/17 | ACOR | Health | BioPrd | Biological Products, (No Diag | Scopia Capital Management LP | NY | T | P | 14,730 | 19.23 | 0 | 766 | 10 | 8,475 | I | |||||||||||||||
6/20/17 15:52 | 6/16/17 | ACOR | Health | BioPrd | Biological Products, (No Diag | Cohen Ron | NY | DO | P,CEO | P | 339 | 16.95 | 0 | 20 | 4 | 555 | D | ||||||||||||||
2/17/06 15:48 | 2/15/06 | ACOR | Health | BioPrd | Biological Products, (No Diag | Steinmetz Michael | MA | D | P.d | 1,000 | 6.00 | 2 | 167 | 10 | 1,807 | I | 5 | -1 | -2 | -5 | -37 | -46 | 295 | ||||||||
2/17/06 15:46 | 2/15/06 | ACOR | Health | BioPrd | Biological Products, (No Diag | Fleming Standish | NY | D | P.d | 750 | 6.00 | 2 | 125 | 14 | 999 | I | 5 | -1 | -2 | -5 | -37 | -46 | 295 | ||||||||
2/17/06 15:46 | 2/15/06 | ACOR | Health | BioPrd | Biological Products, (No Diag | Panem Sandra Phd | NY | D | P.d | 250 | 6.00 | 2 | 42 | 6 | 750 | M | 5 | -1 | -2 | -5 | -37 | -46 | 295 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |